Idera Pharmaceuticals

Nordic Nanovector: New on board

Oslo-based Nordic Nanovector has elected Joanna Horobin to its board as Non-executive Board Director. She replaces Renee Tannenbaum who stepped down from the board for personal reasons.

Horobin, who received her medical degree from the University of Manchester, England,  is currently Senior Vice President, Chief Medical Officer and a Member of the Leadership Team at Idera Pharmaceuticals. Prior to this position, she was CMO of Verastem, Inc. and CEO of Syndax Pharmaceuticals.